Latest Breaking News On - Localized gemcitabine - Page 1 : comparemela.com

Treatment with TAR-200 produced complete responses and was well tolerated in patients with Bacillus Calmette-Guérin–unresponsive, high-risk non–muscle-invasive bladder cancer, according to preliminary data from the phase 2b SunRISe-1 trial.

United statesSiamak daneshmandAmerican urological association annual meetingClinical researchBacillus calmette guUrological association annualKeck medicinePatients with bacillus calmette guérin unresponsiveHigh risk non muscle invasive bladder cancerTar 200Phase 2b sunrise 1 trialLocalized gemcitabineNovel intravesical delivery system